Cinclus Pharma Holding AB (publ)

Kvartalsrapporter

Visar 1 grupper

  1. Kvartalsrapport Q1 2026

    ENSV
    →

    Financial Performance

    • Net sales amounted to TSEK 10,036 (0).
    • Operating profit (EBIT) amounted to TSEK -90,854 (-47,519).
    • Net result for the period was TSEK -88,768 (-33,672).
    • Earnings per share before and after dilution were SEK -1.91 (-0.72).
    • Cash and cash equivalents at the end of the period amounted to TSEK 475,849 (523,899).
    • Total cash flow for the period…

    Öppna rapport